Skip to main content
PMC home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1994;3(3):199–204. doi: 10.1155/S096293519400027X

Changes in Mobility of the Golden Hamster with Induction of an IL-1-Induced Arthritis

I G Otterness 1,✉, M L Bliven 1, A J Milici 1
PMCID: PMC2367032  PMID: 18472942

Abstract

Many studies in animals have examined biochemical, immune and histological changes during arthritis; however, the study of the effects of arthritis on mobility has been largely neglected. Interleukin-1, administered by the intraarticular route into hamster knee joints, resulted in inhibition of spontaneous wheel running activity; however, the effect was transient, lasting only through the evening following IL-1 administration. A further injection of IL-1 2 days later showed still greater inhibition of running. The effect again did not extend beyond the first evening after injection. IL-1α and IL-1β showed equivalent effects on mobility, and no evidence was seen for cooperative interaction between them. A 50% inhibition of running occurred at a dose of approximately 10 ng/knee of IL-1α. The effect appeared not to be systemic since intraperitoneal injection required microgram amounts of IL-1 for an equivalent inhibition. At the time mobility had been restored to normal, histological examination showed the continued presence of inflammatory cells, soft tissue swelling and cartilage proteoglycan loss. These results suggest a lack of correlation between inhibition of mobility and histopathological changes in cartilage and soft tissue.

Full Text

The Full Text of this article is available as a PDF (1.1 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Banks W. A., Ortiz L., Plotkin S. R., Kastin A. J. Human interleukin (IL) 1 alpha, murine IL-1 alpha and murine IL-1 beta are transported from blood to brain in the mouse by a shared saturable mechanism. J Pharmacol Exp Ther. 1991 Dec;259(3):988–996. [PubMed] [Google Scholar]
  2. Borer K. T. Characteristics of growth-inducing exercise. Physiol Behav. 1980 Apr;24(4):713–720. doi: 10.1016/0031-9384(80)90402-3. [DOI] [PubMed] [Google Scholar]
  3. Chandrasekhar S., Harvey A. K., Hrubey P. S., Bendele A. M. Arthritis induced by interleukin-1 is dependent on the site and frequency of intraarticular injection. Clin Immunol Immunopathol. 1990 Jun;55(3):382–400. doi: 10.1016/0090-1229(90)90126-b. [DOI] [PubMed] [Google Scholar]
  4. Chiplunkar S., Langhorne J., Kaufmann S. H. Stimulation of B cell growth and differentiation by murine recombinant interleukin 1. J Immunol. 1986 Dec 15;137(12):3748–3752. [PubMed] [Google Scholar]
  5. Chizzonite R., Truitt T., Kilian P. L., Stern A. S., Nunes P., Parker K. P., Kaffka K. L., Chua A. O., Lugg D. K., Gubler U. Two high-affinity interleukin 1 receptors represent separate gene products. Proc Natl Acad Sci U S A. 1989 Oct;86(20):8029–8033. doi: 10.1073/pnas.86.20.8029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Daumy G. O., Merenda J. M., McColl A. S., Andrews G. C., Franke A. E., Geoghegan K. F., Otterness I. G. Isolation and characterization of biologically active murine interleukin-1 alpha derived from expression of a synthetic gene in Escherichia coli. Biochim Biophys Acta. 1989 Sep 14;998(1):32–42. doi: 10.1016/0167-4838(89)90115-5. [DOI] [PubMed] [Google Scholar]
  7. Daumy G. O., Wilder C. L., Merenda J. M., McColl A. S., Geoghegan K. F., Otterness I. G. Reduction of biological activity of murine recombinant interleukin-1 beta by selective deamidation at asparagine-149. FEBS Lett. 1991 Jan 14;278(1):98–102. doi: 10.1016/0014-5793(91)80093-i. [DOI] [PubMed] [Google Scholar]
  8. DeMarco D., Kunkel S. L., Strieter R. M., Basha M., Zurier R. B. Interleukin-1 induced gene expression of neutrophil activating protein (interleukin-8) and monocyte chemotactic peptide in human synovial cells. Biochem Biophys Res Commun. 1991 Jan 31;174(2):411–416. doi: 10.1016/0006-291x(91)91431-b. [DOI] [PubMed] [Google Scholar]
  9. Dingle J. T., Page Thomas D. P., King B., Bard D. R. In vivo studies of articular tissue damage mediated by catabolin/interleukin 1. Ann Rheum Dis. 1987 Jul;46(7):527–533. doi: 10.1136/ard.46.7.527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Dingle J. T., Saklatvala J., Hembry R., Tyler J., Fell H. B., Jubb R. A cartilage catabolic factor from synovium. Biochem J. 1979 Oct 15;184(1):177–180. doi: 10.1042/bj1840177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Dunn A. J., Antoon M., Chapman Y. Reduction of exploratory behavior by intraperitoneal injection of interleukin-1 involves brain corticotropin-releasing factor. Brain Res Bull. 1991 Apr;26(4):539–542. doi: 10.1016/0361-9230(91)90092-x. [DOI] [PubMed] [Google Scholar]
  12. Dunn C. J., Hardee M. M., Staite N. D. Acute and chronic inflammatory responses to local administration of recombinant IL-1 alpha, IL-beta, TNF alpha, IL-2 and Ifn gamma in mice. Agents Actions. 1989 Jun;27(3-4):290–293. doi: 10.1007/BF01972801. [DOI] [PubMed] [Google Scholar]
  13. Feige U., Karbowski A., Rordorf-Adam C., Pataki A. Arthritis induced by continuous infusion of hr-interleukin-1 alpha into the rabbit knee-joint. Int J Tissue React. 1989;11(5):225–238. [PubMed] [Google Scholar]
  14. Fibbe W. E., van Damme J., Billiau A., Voogt P. J., Duinkerken N., Kluck P. M., Falkenburg J. H. Interleukin-1 (22-K factor) induces release of granulocyte-macrophage colony-stimulating activity from human mononuclear phagocytes. Blood. 1986 Dec;68(6):1316–1321. [PubMed] [Google Scholar]
  15. Havell E. A., Moldawer L. L., Helfgott D., Kilian P. L., Sehgal P. B. Type I IL-1 receptor blockade exacerbates murine listeriosis. J Immunol. 1992 Mar 1;148(5):1486–1492. [PubMed] [Google Scholar]
  16. Hukkanen M., Grönblad M., Rees R., Kottinen Y. T., Gibson S. J., Hietanen J., Polak J. M., Brewerton D. A. Regional distribution of mast cells and peptide containing nerves in normal and adjuvant arthritic rat synovium. J Rheumatol. 1991 Feb;18(2):177–183. [PubMed] [Google Scholar]
  17. Kaye J., Gillis S., Mizel S. B., Shevach E. M., Malek T. R., Dinarello C. A., Lachman L. B., Janeway C. A., Jr Growth of a cloned helper T cell line induced by a monoclonal antibody specific for the antigen receptor: interleukin 1 is required for the expression of receptors for interleukin 2. J Immunol. 1984 Sep;133(3):1339–1345. [PubMed] [Google Scholar]
  18. McIntosh J. K., Jablons D. M., Mulé J. J., Nordan R. P., Rudikoff S., Lotze M. T., Rosenberg S. A. In vivo induction of IL-6 by administration of exogenous cytokines and detection of de novo serum levels of IL-6 in tumor-bearing mice. J Immunol. 1989 Jul 1;143(1):162–167. [PubMed] [Google Scholar]
  19. Newton R. C., Uhl J., Covington M., Back O. The distribution and clearance of radiolabeled human interleukin-1 beta in mice. Lymphokine Res. 1988 Fall;7(3):207–216. [PubMed] [Google Scholar]
  20. Otterness I. G., Gans D. J. Nonsteroidal anti-inflammatory drugs: an analysis of the relationship between laboratory animal and clinical doses, including species scaling. J Pharm Sci. 1988 Sep;77(9):790–795. doi: 10.1002/jps.2600770915. [DOI] [PubMed] [Google Scholar]
  21. Otterness I. G., Golden H. W., Brissette W. H., Seymour P. A., Daumy G. O. Effects of continuously administered murine interleukin-1 alpha: tolerance development and granuloma formation. Infect Immun. 1989 Sep;57(9):2742–2750. doi: 10.1128/iai.57.9.2742-2750.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Otterness I. G., Seymour P. A., Golden H. W., Reynolds J. A., Daumy G. O. The effects of continuous administration of murine interleukin-1 alpha in the rat. Physiol Behav. 1988;43(6):797–804. doi: 10.1016/0031-9384(88)90379-4. [DOI] [PubMed] [Google Scholar]
  23. Perretti M., Solito E., Parente L. Evidence that endogenous interleukin-1 is involved in leukocyte migration in acute experimental inflammation in rats and mice. Agents Actions. 1992 Jan;35(1-2):71–78. doi: 10.1007/BF01990954. [DOI] [PubMed] [Google Scholar]
  24. Pettipher E. R., Higgs G. A., Henderson B. Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc Natl Acad Sci U S A. 1986 Nov;83(22):8749–8753. doi: 10.1073/pnas.83.22.8749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Reimers J., Wogensen L. D., Welinder B., Hejnaes K. R., Poulsen S. S., Nilsson P., Nerup J. The pharmacokinetics, distribution and degradation of human recombinant interleukin 1 beta in normal rats. Scand J Immunol. 1991 Nov;34(5):597–610. doi: 10.1111/j.1365-3083.1991.tb01583.x. [DOI] [PubMed] [Google Scholar]
  26. Saklatvala J., Pilsworth L. M., Sarsfield S. J., Gavrilovic J., Heath J. K. Pig catabolin is a form of interleukin 1. Cartilage and bone resorb, fibroblasts make prostaglandin and collagenase, and thymocyte proliferation is augmented in response to one protein. Biochem J. 1984 Dec 1;224(2):461–466. doi: 10.1042/bj2240461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Schwab J. H., Anderle S. K., Brown R. R., Dalldorf F. G., Thompson R. C. Pro- and anti-inflammatory roles of interleukin-1 in recurrence of bacterial cell wall-induced arthritis in rats. Infect Immun. 1991 Dec;59(12):4436–4442. doi: 10.1128/iai.59.12.4436-4442.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Stimpson S. A., Dalldorf F. G., Otterness I. G., Schwab J. H. Exacerbation of arthritis by IL-1 in rat joints previously injured by peptidoglycan-polysaccharide. J Immunol. 1988 May 1;140(9):2964–2969. [PubMed] [Google Scholar]
  29. Tyler J. A. Chondrocyte-mediated depletion of articular cartilage proteoglycans in vitro. Biochem J. 1985 Jan 15;225(2):493–507. doi: 10.1042/bj2250493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. van de Loo A. A., van den Berg W. B. Effects of murine recombinant interleukin 1 on synovial joints in mice: measurement of patellar cartilage metabolism and joint inflammation. Ann Rheum Dis. 1990 Apr;49(4):238–245. doi: 10.1136/ard.49.4.238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. van de Loo F. A., Arntz O. J., Otterness I. G., van den Berg W. B. Protection against cartilage proteoglycan synthesis inhibition by antiinterleukin 1 antibodies in experimental arthritis. J Rheumatol. 1992 Mar;19(3):348–356. [PubMed] [Google Scholar]
  32. van den Berg W. B., van de Loo F. A., Zwarts W. A., Otterness I. G. Effects of murine recombinant interleukin 1 on intact homologous articular cartilage: a quantitative and autoradiographic study. Ann Rheum Dis. 1988 Oct;47(10):855–863. doi: 10.1136/ard.47.10.855. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES